Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma

The recurrence rate after surgery in patients with hepatocellular carcinoma (HCC) is very high, while prognosis is quite poor. However, there is no standard treatment to prevent recurrence of HCC after a curative operation. In this study, we investigated the clinical utilization of an autologous tum...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hum Vaccin Immunother
Autors principals: Shimizu, Koichi, Kotera, Yoshihito, Aruga, Atsushi, Takeshita, Nobuhiro, Katagiri, Satoshi, Ariizumi, Shun-ichi, Takahashi, Yutaka, Yoshitoshi, Kenji, Takasaki, Ken, Yamamoto, Masakazu
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2014
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4896569/
https://ncbi.nlm.nih.gov/pubmed/24419174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.27678
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars